Ascent has been investing in early stage, emerging technology companies since 1985. In backing over 85 companies, Ascent has remained committed to its mission of investing in exceptional entrepreneurs striving to build innovative market leaders. With over 80 years of combined venture capital experience, the Ascent investment team
has managed four venture funds with total commitments of $380M. Ascent is currently investing out of the firm's fourth fund, a $140 million fund launched in 2004.
Named after Boston's historic public meeting grounds, CommonAngels® is a group of 50 leading private investors and several dozen limited partners in two co-investment funds. CommonAngels have rich expertise in over 58 specific sectors; have founded over 115 companies; sold over 100; and participated in over 34 IPOs. CommonAngels finance the region's most innovative high-tech ventures with a focus on capital efficiency: Series A rounds of $500K-$5M with total capital less than $20M.
Flagship Ventures is an early-stage venture capital firm focused on creating, financing, and building innovative companies in the Life Science and Technology sectors. Headquartered in Cambridge, MA, Flagship Ventures was founded in 1999 and manages $700 million in capital. Prior to its founding, Flagship's principals were involved as founders or investors in over 100 firms including: Adolor, AltaVista, Anesta, Antigenics, Aspect Medical, Astral Point, Celera Genomics, ChemGenics Pharmaceuticals, Color Kinetics, Chantry Networks, Cytyc, DataSage, Exact Sciences, IDEXX, PerSeptive Biosystems, Somatogen, Telecorp PCS and TripAdvisor.
Rock Maple Ventures is uniquely positioned to build leading-edge companies through in-depth experience, focus on new investments and a proprietary network for business partnerships. With $80 million in capital and over 30 years of real-world executive, investment and entrepreneurial experience, Rock Maple Ventures is an active, value-added investor with offices in Boston and New York, and invests nationwide wherever promising technology and healthcare companies emerge.
|